Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


HPV Technology Featured at Infection Prevention 2014 Conference

publication date: Nov 6, 2014
author/source: Bioquell

Cleaning techniques and their efficacy against pathogens such as VRE, MERS and SARS are just some of the hot topics infection control professionals have been discussing at this year’s Infection Prevention Conference.

bioquellRight at the heart of these talks is hydrogen peroxide vapour (HPV) technology and best practices.

Bioquell’s Senior Microbiologist, Jon Otter, has presented, along with two of his peers, a study which shows the capacity of pathogens like influenza, MERS and SARS to survive for days on dry surfaces. These can then be transferred from surfaces to hands. Facing this challenge they recommend that healthcare workers need to adopt infection control best practices such as systematic hand hygene procedures and disinfection solutions.

In his presentation, David Weber from the University of North Carolina, has provided an overview of disinfection solutions available on the market and their efficacy against C. difficile, MRSA, VRE and norovirus. He has reviewed the Spaulding classification of disinfectants/sterilants which divides medical devices into categories based on the risk of infection involved with their use. Included in his presentation was HPV which other studies have proved the most efficient against antibiotic-resistant bugs. Bioquell’s recent interventions, to decontaminate facilities across Europe where Ebola patients have been treated, demonstrate its reliability.

The Singapore Hospital presentation has focused on how the use of HPV combined with a range of other measures have reduced the number of VRE cases. The bundle was implemented in February 2013 and records show 9.2 cases per month (95% CI: 6.0—13.2) in March 2013 which reduced to 2.4 cases per month (95% CI: 1.1—4.7) by January 2014.

In her closing lecture, Dr Stephanie Dancer highlights that, “We are facing unprecedented threats to the management of infection all over the world. As we prepare for a world without antibiotics, research, education and policies on screening, isolation, cleaning and infection control have never been more important. Creative thinking, initiative and courage will be required for future management of infection in hospitals and communities everywhere.”

more about bioquell

more news from bioquell 



Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events